65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04371939 (ClinicalTrials.gov)	November 5, 2019	29/4/2020	Efficacy and Safety of Romiplostim Versus Eltrombopagin the Treatment of Thrombocytopenia in Patient ...	Randomized, Two-arm Single-center Phase II Clinical Trial Comparing the Efficacy and Safety of Romip ...	Wiskott-Aldrich Syndrome	Drug: Romiplostim;Drug: Eltrombopag	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	NULL	Recruiting	N/A	18 Years	All	30	Phase 2	Russian Federation
2	NCT00909363 (ClinicalTrials.gov)	June 2009	27/5/2009	Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients	Effects Of EltrombopagOn Thrombocytopenia, Platelet Function and Bleeding In Patients With Wiskott-A ...	Wiskott-Aldrich Syndrome;Thrombocytopenia;Bleeding	Drug: Promacta;Diagnostic Test: blood drawing in patients with WAS;Diagnostic Test: blood drawing in ...	Weill Medical College of Cornell University	Novartis Pharmaceuticals	Terminated	3 Months	80 Years	Male	24	Phase 2	United States

First Previous1Next Last